ScyFIX is hoping to raise $4 million as it seeks FDA approval for a device that uses slight electric shocks to treat degenerative eye disease.
The Chanhassen, Minn.-based company just started the offering, which expires in June 2012, according to a federal Securities and Exchange Commission filing.
Founder and CEO Thomas Harold declined to comment for this article.